Sign Up
Stories
Cencora Reports Revenue Increase
Share
CELSCI Corporation Announces Public Offe...
CIRO Resumes Trading in Cosa Resources C...
Zextras Launches Carbonio Community Edit...
Cemtrex Reports Strong Q1 2024 Financial...
Cencora Q2 2024 Earnings Announcement
Cencora Repurchases Walgreens Shares
Overview
API
Cencora, Inc. reports a 15.0% year-over-year revenue increase in its fiscal year 2024 first quarter, with GAAP diluted EPS at $2.98 and adjusted diluted EPS at $3.28. The company has raised its adjusted diluted EPS guidance for fiscal year 2024 from $12.70 to $13.25 to $13.50, indicating optimism for the rest of the fiscal year.
Ask a question
How does Cencora plan to capitalize on opportunities in the healthcare landscape?
How does Cencora's financial performance reflect the broader trends in the pharmaceutical and healthcare industries?
What factors contributed to the 15.0% year-over-year revenue increase in the fiscal year 2024 first quarter?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Jan 2024
Coverage